In today’s ACT Brief, we examine how AI is enabling continuous trial monitoring and faster site decisions, how provider ...

Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and ...

Findings from the VA’s Diuretic Comparison Project show pragmatic trial designs can achieve strong provider participation when burden is minimized and patient care remains the primary focus.

In today’s ACT Brief, we examine how AI is shifting from pilot programs into daily development workflows, how a new adoption ...

Angela Zubel, chief development officer, Debiopharm, discusses why 2026 marks a shift from AI pilots to broader operational ...

Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and real-time data monitoring can reduce costs, shorten timelines, and limit ...

The Digital Medicine Society (DiMe), through its Digital Health Measurement Collaborative Community (DATAcc), has launched a new educational resource designed to help sponsors and technology ...

This is the Applied Clinical Trials Brief —your fast track to the latest insights shaping clinical operations and drug development.

Mike Wenger, chief innovation officer at CRIO, explains how AI can responsibly support data quality and monitoring with ...

Miriam Dervan, founder & CEO of mdgroup, discusses how patient-centered strategies rooted in empathy and advocacy engagement ...

In today’s ACT Brief, we examine new data on regional variation in clinical trial risk, why patient experience must move from ...

Using KRIs or SDM, sponsors can detect a variety of emerging risks, including inadequate adverse-event reporting, protocol ...